By A team of researchers affiliated with a host of medical institutions across the U.S. has found that the HDAC6 score can be used to predict the response of some types of cancer to administration of the histone ricolinostat.
HDAC6 score found to predict the response of some cancers to ricolinostat
Digital transformation conceptual for next generation technology era
Comments